This page shows the latest neurodegenerative diseases news and features for those working in and with pharma, biotech and healthcare.
Kramer, while Biogen's chief medical officer Alfred Sandrock said the data "underscores that neurodegenerative diseases may not be as intractable as they once seemed.".
Approximately 3 fully matching, plus 46 partially matching documents found.
to tackle unmet needs in neurological diseases.". ... to expand the company's portfolio of therapies for people living with serious neurodegenerative diseases.".
Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and leads its laboratory for the research of neurodegenerative diseases.
neurodegenerative and rare diseases around the world.